Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

R-CHOP with or without Lenalidomide/Bortezomib As a First Line Treatment for Patients with Non-Germinal Center Diffuse Large B Cell Lymphoma (DLBCL) Subtype: Son Espases University Hospital Experience

Sara Aida Jiménez-Julià, Leyre Bento, MD, Adriana Marcela Quintero, Marta Garcia Recio, Jordi Martínez-Serra, PhD, Francesc Mestre, Lucia García, Sandra Pérez, Gaspar Aspas, Paloma López Perezagua, Jaume Daumal, Rafael Ramos, Antonia Sampol, MD PhD, Antonio Gutiérrez, MD PhD

Blood (2018) 132 (Supplement 1): 1710.

https://doi.org/10.1182/blood-2018-99-119138

Published: 2018

Journal Articles

Long Term Follow-up in Mantle Cell Lymphoma Patients Treated with R-GemOx Followed By Consolidation and Rituximab Maintenance

Marta Garcia Recio, Leyre Bento, MD, Sandra Pérez-León, Sara Aida Jiménez-Julià, Jordi Gines, Jordi Martínez-Serra, PhD, Antonia Sampol, MD PhD, Antonio Gutiérrez, MD PhD

Blood (2018) 132 (Supplement 1): 5337.

https://doi.org/10.1182/blood-2018-99-119713

Published: 2018

Journal Articles

Identification of Patients with Follicular Lymphoma Patients at Risk of Failing Frontline Immunochemotherapy and Rituximab Maintenance

Marta Garcia Recio, Sandra Pérez-León, Leyre Bento, MD, Antonio Salar, MD PhD, Blanca Sanchez-Gonzalez, Jordi Gines, Beatriz Robredo, Lucia García, Sara Aida Jiménez-Julià, Jordi Martínez-Serra, PhD, Antonia Sampol, MD PhD, Antonio Gutiérrez, MD PhD

Blood (2018) 132 (Supplement 1): 5339.

https://doi.org/10.1182/blood-2018-99-119551

Published: 2018

Journal Articles

New Prognosis Score Including Absolute Lymphocytes/Monocytes Ratio and Beta2microglobulin in Patients with Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP: Spanish Lymphoma Group Experience (GELTAMO)

Blood (2018) 132 (Supplement 1): 347.

https://doi.org/10.1182/blood-2018-99-118719

Published: 2018

Journal Articles

Nivolumab for Heavily Pretreated Relapsed/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain (Spanish Group of Lymphoma and Bone Marrow Transplantation, GELTAMO)

Carmen Martinez, MD PhD, Cecilia Carpio, MD, Inmaculada Heras, Eduardo Ríos Herranz, MD, Joan Buch, Antonio Gutierrez, MD PhD, Samuel Romero, Izaskun Ceberio, Irene Garcia-Garcia, Antonia Rodriguez Izquierdo, PhD, Rosalia Alonso, Joan Bargay, MD PhD, Cristina Barrenetxea Lekue, PhD, Narvaez Javier, Manuel Espeso de Haro, MD, Luis Palomera, MD PhD, Ramon García-Sanz, MD PhD

Blood (2018) 132 (Supplement 1): 2936.

https://doi.org/10.1182/blood-2018-99-115774

Published: 2018

Journal Articles

Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation: Experience of a Multicenter Study from the Grupo Español De Trasplante Hematopoyético (GETH)

Blood (2018) 132 (Supplement 1): 200.

https://doi.org/10.1182/blood-2018-200

Published: 2018

Journal Articles

Efficacy of Autologous Stem Cell Transplantation in First Complete Remission in Patients with Peripheral T-Cell Lymphoma: A Multicenter Geltamo/FIL Study

Blood (2017) 130 (Supplement 1): 2008.

https://doi.org/10.1182/blood.V130.Suppl_1.2008.2008

Published: 2017

Journal Articles

Evaluation of the MD Anderson Tumor Score and Their Tumor Related Prognostic Variables in the Rituximab Era

Blood (2017) 130 (Supplement 1): 827.

https://doi.org/10.1182/blood.V130.Suppl_1.827.827

Published: 2017

Journal Articles

Geltamo-IPI Distinctly Identifies a Very High Risk Group in Difuse Large B-Cell Lymphoma (DLBCL) of Non B-Germinal-Center Origin Treated with Chemo-Immunotherapy

Blood (2017) 130 (Supplement 1): 1559.

https://doi.org/10.1182/blood.V130.Suppl_1.1559.1559

Published: 2017

Journal Articles

Outcome of Patients with Gamma Delta T Cell Lymphomas: Analysis of 1429 Cases Registered in the Prospective T-Cell Project

Blood (2017) 130 (Supplement 1): 1512.

https://doi.org/10.1182/blood.V130.Suppl_1.1512.1512

Published: 2017

Journal Articles

Brentuximab Vedotin Plus ESHAP (BRESHAP) Is a Highly Effective Combination for Inducing Remission in Refractory and Relapsed Hodgkin Lymphoma Patients Prior to Autologous Stem Cell Transplant: A Trial of the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)

Ramon Garcia-Sanz, MD PhD, Anna Sureda, MD PhD, Ana Pilar Gonzalez, MD, Fatima De la Cruz, MD PhD, Blanca Sanchez-Gonzalez, MD PhD, Antonia Rodriguez, MD PhD, Eva Domingo-Domenech, MD, Moreno Miriam, MD, Moreno Miriam, MD, Javier Lopez, Sr., MD PhD, Piñana Luis Jose, Gabriela Rodríguez, MD PhD, Miguel Canales, MD PhD, Antonio Gutierrez, MD PhD, Maria Dolores Caballero, MD PhD, Carmen Martinez, MD PhD

Blood (2016) 128 (22): 1109.

https://doi.org/10.1182/blood.V128.22.1109.1109

Published: 2016

Journal Articles

Red Cell Distribution Width (RDW) at Diagnosis of Diffuse Large B-Cell Lymphoma (DLBCL) Is Associated to Higher Mortality and Worse Overall Survival

Leyre Bento, MD, Juan Sarmentero, MD, Ana Ortuño, MD, Marta García-Recio, MD, Bernardo Lopez, Jordi Martínez-Serra, PhD, Jose Rodriguez, MD PhD, Antonia Sampol, Antonio Gutierrez, MD PhD

Blood (2016) 128 (22): 5398.

https://doi.org/10.1182/blood.V128.22.5398.5398

Published: 2016

Journal Articles

Red Cell Distribution Width (RDW) at Diagnosis Is Associated to Advanced Stage, Worse Response and Poor Prognosis in Hodgkin Lymphoma

Bernardo Lopez Andrade, MD, Beatriz Robredo, MD, Francesca Sartori, MD, Inés Herráez, MD, Maria Antonia Duran Pastor, MD, Marta Garcia Recio, MD, Jorge Jose Martinez Serra, Leyre Bento, MD, Antonia Sampol, Jose Rodríguez, MD, Antonio Gutierrez, MD PhD

Blood (2016) 128 (22): 5373.

https://doi.org/10.1182/blood.V128.22.5373.5373

Published: 2016

Journal Articles

Addition of Absolute Lymphocytes/Monocytes Ratio Improves the Revised-International Prognostic Index (R-IPI) in Patients with Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP

Leyre Bento, MD, Antonia María Bautista-Gili, MD, Francesc García, Jordi Martínez-Serra, PhD, Lucía García-Mañó, MD, Marta García-Recio, MD, Carmen Ballester, MD, Jordi Ginés, MD, Paloma López, MD, Jaime Daumal, Rafael Ramos, MD, Antonio Salar, MD PhD, Antonia Sampol, MD PhD, Juan Besalduch, MD PhD, Antonio Gutiérrez, MD PhD

Blood (2015) 126 (23): 2654.

https://doi.org/10.1182/blood.V126.23.2654.2654

Published: 2015

Journal Articles

Hypogammaglobulinaemia and Infectious Toxicity Related with the Use of Maintenance Strategies with Rituximab in B Lymphomas

Lucia García Mañó, MD, Leyre Bento, MD, Jordi Martinez-Serra, Antonio Salar, MD PhD, Jose Maria Sanchez Raga, Inés Herráez, MD, Silvia Ruiz-de Gracia, MD, Marta García-Recio, MD, Mariana Ferraro, Francesc Garcia, Juan Besalduch, Antonia Sampol, Antonio Gutierrez, MD PhD

Blood (2015) 126 (23): 5100.

https://doi.org/10.1182/blood.V126.23.5100.5100

Published: 2015

Journal Articles

Validation of the NCCN-IPI for Diffuse Large B-Cell Lymphoma (DLBCL) in a Nation-Wide Spanish Series of 1885 Patients. the Geltamo-IPI Project

Blood (2015) 126 (23): 3955.

https://doi.org/10.1182/blood.V126.23.3955.3955

Published: 2015

Journal Articles

Clinical Results of Gemox-R in Mantle CELL Lymphoma: The Role of Oxaliplatin

Marta García-Recio, MD, Antonio Gutierrez, MD PhD, Antonia Obrador-Hervia, PhD, Lucia García Mañó, MD, Leyre Bento, MD, Juan Besalduch, MD PhD, Jose Rodriguez, MD PhD, Antonia Sampol, Priam Villalonga, PhD, Silvia Fernandez, PhD

Blood (2015) 126 (23): 2722.

https://doi.org/10.1182/blood.V126.23.2722.2722

Published: 2015

Journal Articles

Differential Impact of Relative Dose-Intensity Reductions (DIR) in Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP21 or R-CHOP14

Leyre Bento, MD, Francesc Garcia, PhD, Antonia Maria Bautista-Gili, Blanca Sanchez, Lucia Garcia, MD, Eva Gimeno, Jordi Martinez-serra, PhD, Mariana Ferraro, Raquel Del campo, Javier Vercher, Miguel Scaff, Ana Pacheco, Florencia Garcia, Rafael Ramos, MD, Carmen Ballester, Juan Besalduch, MD PhD, Joan Bargay, MD, Antonio Salar, MD, Antonio Gutierrez, MD PhD

Blood (2014) 124 (21): 3073.

https://doi.org/10.1182/blood.V124.21.3073.3073

Published: 2014

Journal Articles

Bendamustine In Combination With Rituximab As First-Line Treatment For Indolent Non-Hodgkin Lymphoma: Retrospective Analysis Of An Spanish Registry

Silvia Solorzano, Carmen Martinez-Chamorro, Carlos Panizo, Cristina Quero, Guillermo Deben, MD, Jose Paz, Ana Batlle, MD, Alfons Serrano, Zayda Muentes, Antonio Gutierrez, MD, PhD, Jose Francisco Tomas, MD

Blood (2013) 122 (21): 5094.

https://doi.org/10.1182/blood.V122.21.5094.5094

Published: 2013

Journal Articles

Impact Of Dose-Density Delays In Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-CHOP21 Or R-CHOP14

Antonio Gutierrez, MD, PhD, Antonia M Bautista-Gili, MD, Leyre Bento, MD, Ines Herraez, MD, Lucia Garcia, MD, Jordi Martinez-serra, PhD, Antonia Sampol, MD, PhD, Rafael Ramos, MD, Jordi Gines, MD, Carmen Ballester, MD, Albert Perez, MD, Paloma Lopez-Perezagua, MD, Jaime Daumal, MD, Jose Rodriguez, MD, PhD, Juan Besalduch, MD, PhD

Blood (2013) 122 (21): 4374.

https://doi.org/10.1182/blood.V122.21.4374.4374

Published: 2013

NARROW

R-CHOP with or without Lenalidomide/Bortezomib As a First Line Treatment for Patients with Non-Germinal Center Diffuse Large B Cell Lymphoma (DLBCL) Subtype: Son Espases University Hospital Experience

Long Term Follow-up in Mantle Cell Lymphoma Patients Treated with R-GemOx Followed By Consolidation and Rituximab Maintenance

Identification of Patients with Follicular Lymphoma Patients at Risk of Failing Frontline Immunochemotherapy and Rituximab Maintenance

New Prognosis Score Including Absolute Lymphocytes/Monocytes Ratio and Beta2microglobulin in Patients with Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP: Spanish Lymphoma Group Experience (GELTAMO)

Nivolumab for Heavily Pretreated Relapsed/Refractory Hodgkin Lymphoma: Real-Life Experience in Spain (Spanish Group of Lymphoma and Bone Marrow Transplantation, GELTAMO)

Thrombopoietin Receptor Agonists for Severe Thrombocytopenia after Allogeneic Stem Cell Transplantation: Experience of a Multicenter Study from the Grupo Español De Trasplante Hematopoyético (GETH)

Efficacy of Autologous Stem Cell Transplantation in First Complete Remission in Patients with Peripheral T-Cell Lymphoma: A Multicenter Geltamo/FIL Study

Evaluation of the MD Anderson Tumor Score and Their Tumor Related Prognostic Variables in the Rituximab Era

Geltamo-IPI Distinctly Identifies a Very High Risk Group in Difuse Large B-Cell Lymphoma (DLBCL) of Non B-Germinal-Center Origin Treated with Chemo-Immunotherapy

Outcome of Patients with Gamma Delta T Cell Lymphomas: Analysis of 1429 Cases Registered in the Prospective T-Cell Project

Brentuximab Vedotin Plus ESHAP (BRESHAP) Is a Highly Effective Combination for Inducing Remission in Refractory and Relapsed Hodgkin Lymphoma Patients Prior to Autologous Stem Cell Transplant: A Trial of the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)

Red Cell Distribution Width (RDW) at Diagnosis of Diffuse Large B-Cell Lymphoma (DLBCL) Is Associated to Higher Mortality and Worse Overall Survival

Red Cell Distribution Width (RDW) at Diagnosis Is Associated to Advanced Stage, Worse Response and Poor Prognosis in Hodgkin Lymphoma

Addition of Absolute Lymphocytes/Monocytes Ratio Improves the Revised-International Prognostic Index (R-IPI) in Patients with Diffuse Large B Cell Lymphoma (DLBCL) Treated with R-CHOP

Hypogammaglobulinaemia and Infectious Toxicity Related with the Use of Maintenance Strategies with Rituximab in B Lymphomas

Validation of the NCCN-IPI for Diffuse Large B-Cell Lymphoma (DLBCL) in a Nation-Wide Spanish Series of 1885 Patients. the Geltamo-IPI Project

Clinical Results of Gemox-R in Mantle CELL Lymphoma: The Role of Oxaliplatin

Differential Impact of Relative Dose-Intensity Reductions (DIR) in Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP21 or R-CHOP14

Bendamustine In Combination With Rituximab As First-Line Treatment For Indolent Non-Hodgkin Lymphoma: Retrospective Analysis Of An Spanish Registry

Impact Of Dose-Density Delays In Diffuse Large B-Cell Lymphoma (DLBCL) Treated With R-CHOP21 Or R-CHOP14

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only